Assembly Biosciences (ASMB)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 03-2011 | 12-2010 | 09-2010 | 06-2010 | 03-2010 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 14,001 | 14,571 | 0 | 0 | 0 |
| Other current assets | 102 | 19 | 0 | 0 | 0 |
| TOTAL | $14,102 | $14,590 | $0 | $0 | $0 |
| Non-Current Assets | |||||
| PPE Net | 11 | N/A | N/A | N/A | N/A |
| Other Non-Current Assets | 25 | 27 | 0 | 0 | 0 |
| TOTAL | $36 | $27 | $N/A | $N/A | $N/A |
| Total Assets | $14,138 | $14,617 | $0 | $0 | $0 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | N/A | 1,219 | 0 | 0 | 0 |
| Accounts payable and accrued liabilities | 310 | 500 | 0 | 0 | 0 |
| TOTAL | $310 | $1,720 | $0 | $0 | $0 |
| Non-Current Liabilities | |||||
| Long Term Debt | 1,295 | 1,271 | 0 | 0 | 0 |
| TOTAL | $1,295 | $1,271 | $N/A | $N/A | $N/A |
| Total Liabilities | $1,606 | $2,991 | $0 | $0 | $0 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 120 | N/A | N/A | N/A | N/A |
| Common Shares | 7 | 7 | 0 | 0 | 0 |
| Retained earnings | -35,907 | -33,184 | 0 | 0 | 0 |
| TOTAL | $12,532 | $11,626 | $0 | $0 | $0 |
| Total Liabilities And Equity | $14,138 | $14,617 | $0 | $0 | $0 |